Nasopharyngeal swab and pcr for the screening of nasopharyngeal carcinoma in the endemic area: A good supplement to the serologic screening

Head and Neck

Volumn 20, Issue 8, 1998, Pages 732-738

  Sheen, Tzung Shiahn ^a   Ko, Jenq Yuh ^a   Chang, Yen Liang ^b   Chang, Yuan Shau ^a   Huang, Yu Tzu ^c   Chang, Yao ^c   Tsai, Ching Hwa ^c   Hsu, Mow Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Epstein Barr virus; Nasopharyngeal carcinoma; Polymerase chain reaction

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DETECTION; VIRUS GENOME;

ANTIBODIES, VIRAL; DNA PRIMERS; DNA, VIRAL; FEASIBILITY STUDIES; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0031716202     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199812)20:8<732::AID-HED12>3.0.CO;2-A     Document Type: Article

References (34)

1. Department of Health, the Executive Yuan, ROC, 1991. Cancer Registry Annual Report in Taiwan Area, 1986.
2. Hsu MM, Tu SM. Nasopharyngeal carcinoma in Taiwan: clinical manifestations and results of therapy. Cancer 1983;52:362-368.
3. Hsu MM, Huang SC, Lynn TC, Hsieh T, Tu SM. The survival of patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 1982;90:289-295.
4. Huang SC, Liu LT, Lynn TC. Nasopharyngeal cancer: Study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 1985;11: 1789-1793.
5. Zur Hausen H, Schulte-Holthausen H, Klein G, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970;228:1056-1058.
6. Wolf H, zur Hausen H, Becker V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol 1973;244:245-247.
7. Nonoyama M, Huang CH, Pagano JS, Klein G, Singh S. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1973;70:3265-3268.
8. Zhang HY, Qu G, Deng ZW, Yao TH, Glaser R. EpsteinBarr virus DNA in nasopharyngeal biopsies. Virus Res 1989;12:53-60.
9. Shu CH, Chang YS, Liang CL, Liu ST, Lin CZ, Chang P. Distribution of type A and type B EBV in normal individuals and patients with head and neck carcinomas in Taiwan. J Virol Meth 1992;38:123-130.
10. Yeung WM, Zong YS, Chiu CT, et al. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993;53:746-750.
11. Hamilton-Dutoit SJ, Pallesen G. Detection of EpsteinBarr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopathology 1994;25:101-111.
12. Niedobitek G, Hansmann ML, Herbst H, et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991; 165: 17-24.
13. Hording U, Nielsen HW, Albeck H, Daugaard S. Nasopharyngeal carcinoma: histological types and association with Epstein-Barr virus. Oral Oncol Eur J Cancer 1993;29B: 137-139.
14. Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol 1990;28:2398-2402.
15. Chen CL, Wen WN, Chen JY, Hsu MM, Hsu HC. Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization. Intervirology 1993; 36:91-98.
16. Wu TC, Mann RB, Epstein JI, et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. Am J Pathol 1991;138:1461-1469.
17. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Am J Pathol 1995;146:1355-1367.
18. Pearson GR, Weiland LH, Neel HB, et al. Application of Epstein-Barr virus (EBV) serology to the diagnosis of north American nasopharyngeal carcinoma. Cancer 1983; 51:260-268.
19. Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 1982;29:139-141.
20. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 1985;36:545-547.
21. Zong YS, Sham JST, Ng MH, et al. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer 1992;69:3-7.
22. Chen JY, Liu MY, Chen CJ, et al. Antibody to EpsteinBarr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. J Med Virol 1985; 17:47-49.
23. Chen JY, Chen CJ, Liu MY, et al. Antibody to EpsteinBarr virus specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J Med Virol 1989;27:269-273.
24. Hsu MM. Clinical application of Epstein-Barr virus serology for patients with nasopharyngeal carcinoma. In: McCabe BF, Veldman JE, Mogi G, eds. Immunology in otology, rhinology and laryngology. Amsterdam, New York: Kugler Publications, 1992:303-308.
25. Hsu TY, Pai CY, Shieh SM, et al. Use of antigen expressed in bacteria for detection of EBV-specific thymidine kinase antibodies in sera from patients with nasopharyngeal carcinoma. J Med Virol 1992;38:214-219.
26. Liu MT, Lin LS, Yu Y, et al. Use of recombinant Epstein-Barr virus early antigen for detection of antibody in patients with nasopharyngeal carcinoma. Chin Med J Taipei 1996;57:7-15.
27. Stolzenberg MC, Debouze S, Ng M, et al. Purified recombinant EBV deoxyribonuclease in serological diagnosis of nasopharyngeal carcinoma. Int J Cancer 1996;66: 337-341.
28. Liu MY, Chang YL, Ma J, et al. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma. J Med Virol 1997;52:262-269.
29. Shanmugaratnam K, Sobin LH. Histological typing of tumours of the upper respiratory tract and ear. In: World Health Organization. International Histological Classification of Tumours. Berlin: Springer-Verlag, 1991.
30. Sham JST, Wei WI, Kwan WH, Chan CW, Choi PHK, Choy D. Fiberoptic endoscopie examination and biopsy in determining the extent of nasopharyngeal carcinoma. Cancer 1989;64:1838-1842.
31. Sham JST, Wei WI, Zong YS, et al. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet 1990;335:371-374.
32. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-491.
33. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-698.
34. Dong H, Shen S, Huang S, et al. The cytologic diagnosis of nasopharyngeal carcinoma from exfoliated cells collected by suction method. J Laryngol Otol 1983;97:727-734.